Delivery Order SPE2DB20D3103-SPE2DB22FM5B2
Award Date 2/1/22
Potential Completion Date 2/2/22
Potential Value $44K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a $2,384.16 delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RESTASIS 0.05% eye emulsion. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Restasis 0.05% eye emulsion. The $3,827.40 contract has an ultimate completion date of April 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA with a performance period through December...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,262.57 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of RESTASIS 0.05% Eye Emulsion, a prescription pharmaceutical product, with a performance period ending on April 24, 2024. This Delivery Order contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Restasis 0.05% eye emulsion. The $6,003.75 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) on February 2, 2022, with a completion date of February 3, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $1,800.80 for the supply of Restasis 0.05% eye emulsion. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the primary vehicle for the company to provide a comprehensive range...
- This federal contract award is for the delivery of Restasis 0.05% eye emulsion from Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,320.58 delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of January 28, 2022. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
- The Defense Logistics Agency (DLA) awarded a $6,922.41 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office division for the supply of RESTASIS 0.05% eye emulsion. The contract has an ultimate completion date of August 23, 2024 and is not a set-aside. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical through...
- This is a federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, one of the world's largest pharmaceutical distribution companies. The contract is for the supply of RESTASIS 0.05% eye emulsion to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $3,243.30 and a completion date of May 1, 2024. It is a delivery order contract with a firm fixed price pricing type. Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp., a subsidiary of Amerisourcebergen Corporation, is for the delivery of Restasis 0.05% Eye Emulsion to the Defense Logistics Agency (DLA). The contract is a Firm Fixed Price Delivery Order with a ceiling value of $2,701.20 and a completion date of May 13, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of the leading global pharmaceutical distribution company AmerisourceBergen Corporation. The $11,364.34 contract is for the supply of RESTASIS 0.05% eye emulsion to support military treatment programs and facilities. The delivery order falls under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through...